Influence
June 20, 2025

Rectal location and postcolonoscopy colorectal cancer outcomes

Thomas Imperiale

Published in the JAMA Network Open. Here is a link to the article.

Regenstrief Institute authors: Thomas Imperiale, M.D.

This study examines the relationship between the anatomical location of postcolonoscopy colorectal cancers (PCCRCs) and patient mortality outcomes within the Veterans Health Administration (VHA) system. PCCRCs are cancers identified 6 to 36 months after a colonoscopy that failed to detect malignancy, and they are a key quality indicator of colonoscopy performance. While PCCRCs are commonly associated with the proximal colon, recent evidence highlights a notable incidence in the rectum—a region with distinct biological behavior and a tendency for local invasion.

Using VHA-Medicare data from 2003 to 2013, researchers identified 5,248 cases of rectal cancer and compared all-cause mortality (ACM) and cancer-specific mortality (CSM) between rectal PCCRCs and cancers detected within six months of colonoscopy (DCRC). Advanced statistical analyses, including Cox proportional hazards models, revealed no significant differences in ACM or CSM between rectal PCCRCs and rectal DCRCs. Similar comparisons between rectal and right colon PCCRCs yielded no statistically meaningful differences. A modest but statistically significant mortality difference was found when comparing rectal DCRCs to right colon DCRCs.

The findings suggest that rectal location and the PCCRC classification do not substantially impact mortality outcomes. However, limitations such as missing data on patient health factors and potential underreporting of non-VHA colonoscopies warrant cautious interpretation. This study reinforces the need for thorough inspection of the rectum during colonoscopy, as it remains a common site for missed cancers. Further investigation is recommended to understand contributing factors and improve detection strategies.

Authors: 

Charles J. Kahi, MD, MSc1,2,3Laura J. Myers, PhD2,3,5Patrick O. Monahan, PhD4Barry C. Barker, MA3Timothy E. Stump, MA3,4Thomas F. Imperiale, MD1,2,3,5

Affiliations: 

1Department of Medicine, Richard L. Roudebush VA Medical Center, Indianapolis, Indiana
2Health Services Research & Development, Richard L. Roudebush VA Medical Center, Indianapolis, Indiana
3Indiana University School of Medicine, Indianapolis
4Department of Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis
5The Regenstrief Institute, Indianapolis, Indiana

Partners

Related News

(From left to right) Dr. Brian Dixon, Dr. Sanji De Sylva and Isaac Vetter. Photo credit: Svetlana Efimova

Regenstrief experts advance global dialogue on digital health and interoperability at forum in Dubai

Regenstrief informaticians joined global leaders who shared their expertise at the 8th ZIMAM Digital Health Forum November 5-6, in

Regenstrief researchers join national stage to advance aging and gerontology research

Regenstrief Institute research scientists joined leading experts from across the nation at the Gerontological Society of America (GSA) 2025

illustration of the combination of interventions used in the D3 pragmatic clinical trial

Zero-cost, AI-driven digital detection identifies Alzheimer’s and related dementias without additional clinician time

Few primary care practices are designed for the timely detection of Alzheimer’s disease and related dementias. The limited time